Part 9: Pediatric Epilepsy Board Prep Q&A
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
-
Lu par :
-
De :
À propos de ce contenu audio
Summary
This episode of Child Neurology Board Review delves into various pediatric neurological disorders, focusing on Angelman syndrome, benign epilepsy with centrotemporal spikes, infantile spasms, temporal lobe epilepsy, and Dravet syndrome. Each condition is explored through case studies, highlighting symptoms, diagnosis, treatment options, and future directions in research and therapy.
Takeaways
- Angelman syndrome is caused by the loss of function of the UB3A gene.
- Patients with Angelman syndrome exhibit developmental delays and seizures.
- Benign epilepsy with centrotemporal spikes is common in children and often resolves by age 18.
- Hypsarrhythmia is a key EEG finding in infantile spasms.
- Temporal lobe epilepsy can result from childhood febrile seizures.
- Dravet syndrome is a severe genetic epilepsy disorder triggered by fever.
- Avoid sodium channel blockers in Dravet syndrome as they worsen seizures.
- Gene therapy is a promising future direction for genetic epilepsy disorders.
- Early intervention and therapy are crucial for developmental outcomes.
- Regular follow-up is essential for managing pediatric epilepsy.
Sound Bites
- "This is Angelman syndrome."
- "The diagnosis is Angelman syndrome."
- "This is Dravet syndrome."
Chapters
00:00
Understanding Angelman Syndrome
02:50
Benign Epilepsy with Centrotemporal Spikes
05:23
West Syndrome: A Severe Infantile Epilepsy
08:07
Temporal Lobe Epilepsy and Its Implications
10:15
Dravet Syndrome: A Genetic Epilepsy Disorder
11:27
Silent Ocean
Vous êtes membre Amazon Prime ?
Bénéficiez automatiquement de 2 livres audio offerts.Bonne écoute !
Aucun commentaire pour le moment